The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The glaucoma surgery devices market has witnessed rapid growth, driven by various factors and innovative trends shaping the industry’s landscape.

• Market Growth and Projections
  • From $1.73 billion in 2023 to $1.95 billion in 2024, growing at a CAGR of 12.8%.
  • Expected to reach $3.25 billion in 2028, with a CAGR of 13.7%.
• Factors Driving Growth
  • Aging population
  • Rising incidence of glaucoma
  • Increased awareness and screening programs
  • Healthcare infrastructure development
  • Insurance coverage and reimbursement policies

Rising Prevalence Of Glaucoma

• Glaucoma’s progressive nature highlights the importance of advanced glaucoma surgery devices.
• Glaucoma surgery devices play a pivotal role in executing safer, more effective, and less invasive surgeries.
• Statistics project a significant increase in glaucoma cases globally, emphasizing the need for enhanced treatment options.

Key Players in the Glaucoma Surgery Devices Market

• Major companies include:
  • Alcon
  • Johnson & Johnson
  • Abbott Laboratories
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Inc.
  • Topcon Corporation
  • HAAG-Streit Holding AG
  • Essilor International S.A.
  • Hoya Corporation
  • And more…

Read More On The Glaucoma Surgery Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Advanced Goniotomy: Technological Advancements

• Technological advancements drive innovation in the glaucoma surgery devices market.
• Sight Sciences Inc. introduced the SION Surgical Instrument, the first bladeless device used in goniotomy.
• The SION Surgical Instrument offers a safer and controlled approach to goniotomy, enhancing patient outcomes.

Alcon Strengthens Global Surgical Portfolio

• Alcon’s acquisition of Ivantis Inc. expands its surgical portfolio with the Hydrus microstent for glaucoma treatment.
• The Hydrus microstent offers a minimally invasive solution for patients with primary open-angle glaucoma.
• Ivantis Inc. specializes in developing minimally invasive glaucoma surgery (MIGS) devices, reinforcing Alcon’s position in the market.

Market Segmentation

• The glaucoma surgery devices market is segmented based on:
  • Product: Drainage Systems, Laser-Based Devices, Implants, Other Products
  • Treatment: Open-Angle, Closed-Angle
  • Type Of Surgery: Angle Closure Glaucoma Surgery, Aqueous Shunt Surgery, Laser Surgery, Other Type Of Surgeries
  • Application: Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries
  • End User: Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers

Regional Insights

• North America led the glaucoma surgery devices market in 2023.

In conclusion, the rapid growth of the glaucoma surgery devices market reflects the increasing demand for advanced treatment options driven by rising glaucoma prevalence and technological innovations. As key players continue to invest in research and development, collaboration, and strategic acquisitions, the market is poised for further expansion. With a focus on patient-centric solutions and enhanced surgical outcomes, the glaucoma surgery devices market is set to transform ophthalmic care globally.

Request for A Sample Of The Global Glaucoma Surgery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=10173&type=smp